Besides, we also found a high frequency of TP53 mutation in patients with IDH WT, whereas low frequency of TP53 mutation in patients was accompanied with mutated IDH. Adam and colleagues have demonstrated that IDH mutation occurs earlier in the development of glioma and its mutation precedes TP53 mutation (25). This evidence concerns the gene IDH1 and central nervous system cancer.